{"id":"W2953069975","doi":"10.1097/01.hs9.0000561564.12955.95","title":"S821 NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED‐STAGE CLASSICAL HODGKIN LYMPHOMA: 2‐YEAR EXTENDED FOLLOW‐UP FROM COHORT D OF THE PHASE 2 CHECKMATE 205 STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Dacarbazine; Nivolumab; Medicine; Vinblastine; Internal medicine; Oncology; Stage (stratigraphy); Cohort; Chemotherapy; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001462766,0.0006788863,0.0008876193,0.000248259,0.0003603194,0.0007852973,0.0005816648,0.0005329133,0.002206509],"category_scores_gemma":[0.000957834,0.0003247199,0.001413029,0.0002932185,0.0002896741,0.0004189987,0.0004895836,0.001042401,0.0004439498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008780495,"about_ca_system_score_gemma":0.001052068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002460106,"about_ca_topic_score_gemma":0.005084223,"domain_scores_codex":[0.9996475,0.0001487344,0.00002021837,0.00007157114,0.00004740924,0.00006447834],"domain_scores_gemma":[0.9992871,0.00008456608,0.0001628348,0.0001168758,0.0000784668,0.0002701416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6973652,0.02447094,0.1658399,0.001180669,0.006028702,0.0005695227,0.0003587789,0.002502199,0.0190648,0.0002193943,0.01177364,0.0706263],"study_design_scores_gemma":[0.2432989,0.2605453,0.4690234,0.0002253479,0.005226036,0.0009985698,0.00027569,0.002436295,0.004323978,0.0002180636,0.01334683,0.00008159102],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942541,0.0008690279,0.0001523311,0.00008824845,0.00004078954,0.0005972154,0.003287116,0.00001808793,0.0006930887],"genre_scores_gemma":[0.9840539,0.0006964234,0.000506906,0.0005093816,0.00008211857,0.00077795,0.01214653,0.00001173683,0.001214986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002460106,"threshold_uncertainty_score":0.007735968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01276875105813574,"score_gpt":0.27930889893961,"score_spread":0.2665401478814743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}